
Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Jonathan G. Marquess, PharmD, CDE, discusses the role that pharmacists can play in helping patients improve management of their diabetes.
In this video, Jonathan G. Marquess, PharmD, CDE, President and CEO of the Institute for Wellness and Education, Inc, discusses the role that pharmacists can play in helping patients improve management of their diabetes. This video was shot at the National Community Pharmacists Association 115th Annual Convention in Orlando.






